Advertisement

Rheumatology

Prevalence of Arthritis Higher Among Caregivers

Nov 05, 2022

THURSDAY, Nov. 3, 2022 (HealthDay News) -- The prevalence of arthritis is higher among caregivers than noncaregivers, and caregivers with arthritis are more likely to report disabilities, according t...

ASA: Green Light Therapy for Pain-Related Anxiety Studied in Fibromyalgia

Nov 02, 2022

TUESDAY, Nov. 1, 2022 (HealthDay News) -- Green light therapy might decrease anxiety, particularly fear-based anxiety, in patients with fibromyalgia and reduce the use of opioids to manage chronic pai...

1999 to 2018 Saw Increase in Barriers to Timely Medical Care

Nov 01, 2022

FRIDAY, Oct. 28, 2022 (HealthDay News) -- From 1999 to 2018, barriers to timely medical care in the United States increased for all race and ethnic groups, with disparities between groups also increas...

Higher Work Hours Linked to Depressive Symptoms for Interns

Oct 28, 2022

THURSDAY, Oct. 27, 2022 (HealthDay News) -- For interns, higher work hours are associated with increased depressive symptoms, according to a letter to the editor published in the Oct. 20 issue of the ...

Female Med Students Publish Less, Despite Higher Number of Research Experiences

Oct 27, 2022

WEDNESDAY, Oct. 26, 2022 (HealthDay News) -- Among medical school students, there are significant disparities in publication rates across sex and race and ethnicity, according to a study published onl...

Female Med Students Publish Less, Despite Higher Number of Research Experiences

Oct 27, 2022

WEDNESDAY, Oct. 26, 2022 (HealthDay News) -- Among medical school students, there are significant disparities in publication rates across sex and race and ethnicity, according to a study published onl...

Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout

Oct 21, 2022

1. The composite score for non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death was comparable between allopurinol (11.0%) and usual care (11.3%). 2. All-cause mortality was sim...

Physicians With Disabilities Experience More Mistreatment

Oct 20, 2022

WEDNESDAY, Oct. 19, 2022 (HealthDay News) -- Physicians with disabilities had a significantly higher likelihood of experiencing every type of mistreatment from both patients and coworkers, according t...

Comorbidity Burden Higher in Generalized Pustular Psoriasis

Oct 20, 2022

WEDNESDAY, Oct. 19, 2022 (HealthDay News) -- Patients with generalized pustular psoriasis (GPP) have increased comorbidity compared with the general population and with patients with psoriasis vulgari...

Biomarkers May ID RA Patients With, Without Active Disease

Oct 20, 2022

THURSDAY, Oct. 20, 2022 (HealthDay News) -- Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) values may differentiate between rheumatoid arthritis (RA) patients with and wit...

#VisualAbstract: Intravenous immune globulin improved disease severity in dermatomyositis

Oct 15, 2022

  1. Patients with dermatomyositis treated with intravenous immune globulin (IVIG) were more likely to see improvement in their disease severity compared to placebo at 16 weeks of follow-u...

APS Patients: Association Between Livedo Reticularis & Arterial Thrombosis

Oct 14, 2022

Antiphospholipid antibodies (aPLs) linked to thrombosis (arterial and/or venous) and/or obstetrical symptoms are the hallmark of antiphospholipid syndrome (APS). However, APS typically has a number of...

Rheumatology Clinic Staff Needs

Oct 14, 2022

Due to inflammatory and conventional risk factors, including smoking and high blood pressure (BP), patients with rheumatologic disorders have an increased chance of developing cardiovascular disease (...

SLE Patients: Ramipril Improves Endothelial Function & Increases the Number of EPCs

Oct 14, 2022

Patients with systemic lupus erythematosus (SLE) may develop cardiovascular disease as a result of endothelial dysfunction and a decrease in endothelial progenitor cells (EPCs) in peripheral blood. Va...

Mass Switch From IV to Subcutaneous TCZ: Rheumatic Diseases

Oct 14, 2022

It was suggested to switch from intravenous (IV) tocilizumab (TCZ) to its subcutaneous formulation with the arrival of the SARS-CoV-2 pandemic in 2020 to prevent rheumatological patients from having t...

Programmed Death 1 Pathway Inhibitors in Patients

Oct 14, 2022

For a study, researchers sought to assess the safety of programmed death 1 inhibitors in individuals with autoimmune disease. Adults with solid tumor malignancies who received ≥1 dose of pembroli...

Impact of Stress During the COVID-19 Pandemic on RA Patients' Disease Activity

Oct 14, 2022

The COVID-19 pandemic has raised worry and anxiety in rheumatoid arthritis (RA) sufferers, and psychological stress increases disease activity. For a study, researchers sought to ascertain if stress e...

Thirty-Seven Percent of Adults Used Telemedicine in 2021

Oct 14, 2022

THURSDAY, Oct. 13, 2022 (HealthDay News) -- In 2021, 37.0 percent of adults used telemedicine in the past 12 months, with use varying by age, sex, and race/ethnicity, according to an October data bri...

Lenabasum Studied for Refractory Cutaneous Dermatomyositis

Oct 12, 2022

TUESDAY, Oct. 11, 2022 (HealthDay News) -- Lenabasum is well tolerated for the treatment of amyopathic dermatomyositis, according to a phase 2 study published online Oct. 1 in the Journal of Investiga...

Most Safety Signals Reported to FDA Lead to Regulatory Action

Oct 07, 2022

THURSDAY, Oct. 6, 2022 (HealthDay News) -- Most potential safety signals identified from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) led to FDA regulatory action, acco...